Chao Song
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Chao Song has a total of 21 co-authors. Here are the top co-authors by number of shared publications:
- Junwei Liu
Department of Urology Renmin Hospital of Wuhan University Zhangzhidong Road 99 Wuhan Hubei 430060 China
2 shared publications - Sixing Yang
Department of Urology, Renmin Hospital of Wuhan University, Wuhan, China
2 shared publications - Wenbiao Liao
Department of Urology Renmin Hospital of Wuhan University Wuhan Hubei Province China
2 shared publications - Alexander de Groot
Department of Global Access Value Economics, Intuitive, Sunnyvale, USA
1 shared publication - Bin Li
Department of Urology
1 shared publication - Daniel Sunho Oh
Division of Thoracic Surgery, Department of Surgery, Keck School of Medicine, University of Southern California, Los Angeles, USA
1 shared publication
Latest Publications
- Open Access
- 2 January 2024
- Published by Wiley in Journal of Cellular and Molecular Medicine
- Vol. 28 (5)
Immunotherapeutic prospects and progress in bladder cancer
Bladder cancer is one of the most common malignant tumours of the urogenital system, with high morbidity and mortality. In most cases, surgery is considered the first choice of treatment, followed by adjuvant chemotherapy. However, the 5‐year recurrence rate is still as high as 65% in patients with non‐invasive or in situ tumours and up to 73% in patients with slightly more advanced disease at initial diagnosis. Various treatment methods for bladder cancer have been developed, and hundreds of new immunotherapies are being tested. To date, only a small percentage of people have had success with new treatments, though studies have suggested that the combination of immunotherapy with other therapies improves treatment efficiency and positive outcomes for individuals, with great hopes for the future. In this article, we summarize the origins, therapeutic mechanisms and current status of research on immunotherapeutic agents for bladder cancer.
- 2 January 2024
- Published by Wiley in Journal of Cellular and Molecular Medicine
- Vol. 28 (5)
Open AccessImmunotherapeutic prospects and progress in bladder cancer
Bladder cancer is one of the most common malignant tumours of the urogenital system, with high morbidity and mortality. In most cases, surgery is considered the first choice of treatment, followed by adjuvant chemotherapy. However, the 5‐year recurrence rate is still as high as 65% in patients with non‐invasive or in situ tumours and up to 73% in patients with slightly more advanced disease at initial diagnosis. Various treatment methods for bladder cancer have been developed, and hundreds of new immunotherapies are being tested. To date, only a small percentage of people have had success with new treatments, though studies have suggested that the combination of immunotherapy with other therapies improves treatment efficiency and positive outcomes for individuals, with great hopes for the future. In this article, we summarize the origins, therapeutic mechanisms and current status of research on immunotherapeutic agents for bladder cancer.
- Open Access
- 25 February 2022
- Published by Springer Nature in Surgical Endoscopy
- Vol. 36 (9) , 7075
Publisher Correction: Impact of type of minimally invasive approach on open conversions across ten common procedures in different specialties
- 25 February 2022
- Published by Springer Nature in Surgical Endoscopy
- Vol. 36 (9) , 7075
Open AccessPublisher Correction: Impact of type of minimally invasive approach on open conversions across ten common procedures in different specialties
- Open Access
- 1 January 2021
- Published by Wiley in Oxidative Medicine and Cellular Longevity
- Vol. 2021 (1)
Oxalate Activates Autophagy to Induce Ferroptosis of Renal Tubular Epithelial Cells and Participates in the Formation of Kidney Stones
Renal tubular epithelial cell damage is the basis for the formation of kidney stones. Oxalate can induce human proximal tubular (HK‐2) cells to undergo autophagy and ferroptosis. The present study was aimed at investigating whether the ferroptosis of HK‐2 cells induced by oxalate is caused by the excessive activation of autophagy. We treated HK‐2 cells with 2 mmol/L of oxalate to establish a kidney stone model. First, we tested the degree of oxidative damage and the level of autophagy and ferroptosis in the control group and the oxalate intervention group. We then knocked down and overexpressed the BECN1 gene and knocked down the NCOA4 gene in HK‐2 cells, followed by redetection of the above indicators. We confirmed that oxalate could induce autophagy and ferroptosis in HK‐2 cells. Moreover, after oxalate treatment, overexpression of the BENC1 gene increased cell oxidative damage and ferroptosis. In addition, knockdown of NCOA4 reversed the effect of oxalate‐induced ferroptosis in HK‐2 cells. Our results show that the effects of oxalate on the ferroptosis of HK‐2 cells are caused by the activation of autophagy, and knockdown of the NCOA4 could ameliorate this effect.
- 1 January 2021
- Published by Wiley in Oxidative Medicine and Cellular Longevity
- Vol. 2021 (1)
Open AccessOxalate Activates Autophagy to Induce Ferroptosis of Renal Tubular Epithelial Cells and Participates in the Formation of Kidney Stones
Renal tubular epithelial cell damage is the basis for the formation of kidney stones. Oxalate can induce human proximal tubular (HK‐2) cells to undergo autophagy and ferroptosis. The present study was aimed at investigating whether the ferroptosis of HK‐2 cells induced by oxalate is caused by the excessive activation of autophagy. We treated HK‐2 cells with 2 mmol/L of oxalate to establish a kidney stone model. First, we tested the degree of oxidative damage and the level of autophagy and ferroptosis in the control group and the oxalate intervention group. We then knocked down and overexpressed the BECN1 gene and knocked down the NCOA4 gene in HK‐2 cells, followed by redetection of the above indicators. We confirmed that oxalate could induce autophagy and ferroptosis in HK‐2 cells. Moreover, after oxalate treatment, overexpression of the BENC1 gene increased cell oxidative damage and ferroptosis. In addition, knockdown of NCOA4 reversed the effect of oxalate‐induced ferroptosis in HK‐2 cells. Our results show that the effects of oxalate on the ferroptosis of HK‐2 cells are caused by the activation of autophagy, and knockdown of the NCOA4 could ameliorate this effect.